Position in ARVN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$787,929
+$648,804 QoQ
Shares Held
94,817
+622.4% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 198 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 33%
Shared 0%
None 67%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. ARVN ranks #42 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in ARVN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $787,929 | 94,817 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $139,125 | 13,125 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $38,343 | 3,233 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $143,340 | 16,824 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $292,935 | 39,801 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $196,988 | 28,061 | Shares | Sole | 2025-05-05 | |
| 2024-09-30 | $700,033 | 28,422 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $756,593 | 28,422 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,233,528 | 29,882 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $1,147,911 | 27,889 | Shares | Sole | 2024-02-06 | |
| 2022-12-31 | $281,993 | 8,243 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $397,384 | 8,932 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $314,117 | 7,463 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $633,831 | 9,418 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $788,461 | 9,599 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $795,913 | 9,685 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $668,360 | 8,680 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $801,528 | 12,126 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $2,492,780 | 29,351 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $759,793 | 32,181 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $552,940 | 16,486 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||